[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-348957-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-348957-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","clinical-applications-of-phosphoproteomics-illuminating-cancer-signaling-and-enabling-rational-therapeutic-strategies","Clinical Applications of Phosphoproteomics: Illuminating Cancer Signaling and Enabling Rational Therapeutic Strategies","","Protein phosphorylation is a central post-translational modification controlling cellular signaling and is frequently dysregulated in cancer. Mass spectrometry (MS)-based phosphoproteomics systematically profiles phosphorylation events to expose aberrant kinase activity and therapeutic vulnerabilities missed by genomic or transcriptomic analyses. The review summarizes workflow advances in sample prep, enrichment, quantitative strategies, high-resolution MS, site identification algorithms, and integrative informatics. Applied to clinical specimens and patient-derived cancer cells, these studies map signaling pathways, identify targetable kinases, validate therapeutic strategies, and support precision oncology.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/clinical-applications-of-phosphoproteomics-illuminating-cancer-signaling-and-enabling-rational-therapeutic-strategies/348957/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/clinical-applications-of-phosphoproteomics-illuminating-cancer-signaling-and-enabling-rational-therapeutic-strategies/348957.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is protein phosphorylation important in cancer signaling?","Question",{"text":63,"@type":64},"Protein phosphorylation regulates key cellular signaling processes, and it is commonly dysregulated in cancer, driving abnormal kinase pathway activity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does MS-based phosphoproteomics contribute to precision oncology?",{"text":68,"@type":64},"MS-based phosphoproteomics enables comprehensive, quantitative mapping of phosphorylation events, revealing therapeutic vulnerabilities and informing targetable kinase strategies.",{"name":70,"@type":61,"acceptedAnswer":71},"What workflow improvements are highlighted in the review?",{"text":72,"@type":64},"The review emphasizes advances in sample preparation and phosphopeptide enrichment, isotope or label-free quantification, high-resolution MS platforms, specialized algorithms for site identification and quantification, and integrative informatics analysis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},348957,1790218962,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Cancer Science  \nClinical Applications of Phosphoproteomics: Illuminating Cancer Signaling and Enabling Rational Therapeutic Strategies  \nHirokazu Shoji1,2  | Narikazu Boku1,3 | Jun Adachi4,5   \n1Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan | 2Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan | 3Department of Medical Oncology and General Medicine, IMSUT Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan | 4Laboratory of Proteomics for Drug Discovery, Center for Drug Design Research, National Institute of Biomedical Innovation, Health, and Nutrition, Osaka, Japan | 5Laboratory of Proteomics and Drug Discovery, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan  \nCorrespondence: Jun Adachi ([jun_adachi@nibn.go.jp](jun_adachi@nibn.go.jp))  \nReceived: 30 September 2025 | Revised: 24 December 2025 | Accepted: 6 January 2026  \nKeywords: cancer signaling | kinases | mass spectrometry | phosphoproteomics | therapeutic targets  \nABSTRACT  \nProtein phosphorylation is a central post-translational modification regulating cellular signaling, frequently dysregulated in cancer. Mass spectrometry (MS)-based phosphoproteomics has emerged as a powerful approach to systematically profile phosphorylation events, thereby revealing aberrant kinase activity and therapeutic vulnerabilities that are not captured by genomic or transcriptomic analyses. Recent advances across the workflow—including optimized sample preparation and phosphopeptide enrichment, isotope-or label-free quantitative strategies, high-resolution mass spectrometry platforms, specialized algorithms for site identification and quantification, and integrative informatics analyses—have enabled the detection of tens of thousands of phosphorylation sites even from small clinical specimens. These developments have facilitated the characterization of signaling pathways across diverse cancer types, leading to the identification of targetable kinases and informing therapeutic strategies. In this review, we highlight studies that employed phosphoproteomic analyses of clinical specimens or patient-derived cancer cells to delineate signaling characteristics and to propose and validate therapeutic targets. Collectively, MS-based phosphoproteomics is poised to become a cornerstone of precision oncology. By enabling comprehensive and quantitative mapping of phosphorylation events, this technology allows mechanistic dissection of cancer signaling pathways and uncovers therapeutic vulnerabilities that may be exploited with targeted agents.  \n\n| Abbreviations: ABL, abelson murine leukemia viral oncogene homolog; AML, acute myeloid leukemia; AXL, anexelekto receptor tyrosine kinase; CML, chronic myeloid leukemia; CPTAC, clinical proteomic tumor analysis consortium; CRC, colorectal cancer; DDA, data-dependent acquisition; DIA, data-independent acquisition; EGFR, epidermal growth factor receptor; EMT, epithelial-mesenchymal transition; ERK, extracellular signal-regulated kinase; ETD, electron transfer dissociation; EThcD, electron transfer/higher energy collision dissociation; FDA, U.S. Food and Drug Administration; FT-ICR, fourier transform ion cyclotron resonance; HCD, higher-energy collisional dissociation; IMAC, immobilized metal ion affinity chromatography; IMS, ion mobility separation; iTRAQ, isobaric tags for relative and absolute quantification; LC–MS/MS, liquid chromatography–tandem mass spectrometry; LFQ, label-free quantification; MOAC, metal oxide affinity chromatography; MS, mass spectrometry; MS/MS, tandem mass spectrometry; mTOR, mechanistic target of rapamycin; NAT, normal adjacent tissue; PAK1,\u003Cbr>p21-activated kinase 1; PASEF, parallel accumulation–serial fragmentation; PDAC, pancreatic ductal adenocarcinoma; PDX, patient-derived xenograft; PI3K, phosphoinositide 3-kinase; PRM, parallel reaction monitoring; Rb, retinoblastoma protein. |\n| --- |\n| This is","cbCaigc7Qo6NWE7M","https://ap.wps.com/l/cbCaigc7Qo6NWE7M","pdf",1300676,11,"English","# Abstract\n## Introduction\n## Abbreviations","[{\"question\":\"Why is protein phosphorylation important in cancer signaling?\",\"answer\":\"Protein phosphorylation regulates key cellular signaling processes, and it is commonly dysregulated in cancer, driving abnormal kinase pathway activity.\"},{\"question\":\"How does MS-based phosphoproteomics contribute to precision oncology?\",\"answer\":\"MS-based phosphoproteomics enables comprehensive, quantitative mapping of phosphorylation events, revealing therapeutic vulnerabilities and informing targetable kinase strategies.\"},{\"question\":\"What workflow improvements are highlighted in the review?\",\"answer\":\"The review emphasizes advances in sample preparation and phosphopeptide enrichment, isotope or label-free quantification, high-resolution MS platforms, specialized algorithms for site identification and quantification, and integrative informatics analysis.\"}]","Clinical Applications of Phosphoproteomics: Illuminating Cancer Signaling and Enabling Rational Therapeutic Strategies | PDF",1790080834,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e770e44a826ee9b34a40ae5dc07f59c9.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e29868fbd409d0f870759c98e5e84a5d.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0364968eea23954758567f3845172b43.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07b11139aba7260cb151890f401ce650.webp",980,1287]